You are here:Home-Conferences-Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process (ASM/ESCMID 2019)

Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process (ASM/ESCMID 2019)

Antibiotic Bootcamps for Developers: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process

ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

3-6 September 2019, Boston

Collaboratively organized by GARDP, CARB-X, REPAIR Impact Fund, JPIMAR and Wellcome Trust


Moderator: Ursula Theuretzbacher (Center for Anti-Infective Agents, Austria)

Speakers: Michael Mourez (Evotec, France), Douglas Huseby (University Uppsala, Sweden)

Q&A session: Michael Mourez (Evotec, France), Douglas Huseby (University Uppsala, Sweden), Mariana Castanheira (JMI Laboratories, U.S.), Ursula Theuretzbacher (Center for Anti-Infective Agents, Austria)


  1. Introductions (John H. Rex & Ursula Theuretzbacher)
  2. Testing for the Potential of Emergence of Resistance (Michael Mourez)
  3. Improving Predictions of the Risk of Emergence of Resistance (Douglas Huseby)
  4. Questions & answers
2019-11-29T13:12:57+00:00